Health Trials

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

ConditionAlopecia Areata
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age12+
SponsorPfizer

About this trial

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Ritlecitinib

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Pfizer

Lead sponsor

Source ClinicalTrials.gov